Log in
Enquire now
‌

US Patent 11833173 Th1 vaccination priming for active immunotherapy

Patent 11833173 was granted and assigned to Mirror Biologics, Inc. on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Mirror Biologics, Inc.
Mirror Biologics, Inc.
0
Current Assignee
Mirror Biologics, Inc.
Mirror Biologics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118331730
Patent Inventor Names
Michael Har-Noy0
Date of Patent
December 5, 2023
0
Patent Application Number
169288840
Date Filed
July 14, 2020
0
Patent Citations
‌
US Patent 7435592 Compositions for allogeneic cell therapy
0
‌
US Patent 7402431 T-cell therapy formulation
0
Patent Primary Examiner
‌
Amy E Juedes
0
Patent abstract

The present invention includes vaccine compositions and methods for using these vaccine compositions in active immunotherapy. The vaccine compositions include allogeneic activated Th1 memory cells. The compositions can also include one or more disease-related antigens. The methods include administering the vaccine compositions to provide a Th1 footprint in normal individuals or patients susceptible to disease or having minimal residual disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11833173 Th1 vaccination priming for active immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.